165 related articles for article (PubMed ID: 16794999)
21. Endothelin-1 and nitric oxide in patients on chronic hemodialysis.
Tomić M; Galesić K; Markota I
Ren Fail; 2008; 30(9):836-42. PubMed ID: 18925520
[TBL] [Abstract][Full Text] [Related]
22. Renin-secreting tumors.
Corvol P; Pinet F; Plouin PF; Bruneval P; Menard J
Endocrinol Metab Clin North Am; 1994 Jun; 23(2):255-70. PubMed ID: 8070421
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
24. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
[TBL] [Abstract][Full Text] [Related]
25. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
[TBL] [Abstract][Full Text] [Related]
26. [Study of kini-kallikrein and renin--angiotensin systems in patients with primary open angle glaucoma].
Borovic D; Bendelic E; Chiseliţă D
Oftalmologia; 2009; 53(2):61-8. PubMed ID: 19697842
[TBL] [Abstract][Full Text] [Related]
27. Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
Nussberger J; Gradman AH; Schmieder RE; Lins RL; Chiang Y; Prescott MF
Int J Clin Pract; 2007 Sep; 61(9):1461-8. PubMed ID: 17590217
[TBL] [Abstract][Full Text] [Related]
28. [Stress-associated hypertension in the work place: results of the STARLET project].
Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
[TBL] [Abstract][Full Text] [Related]
29. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
31. Plasma renin activity in Wilms' tumour.
Voûte PA; van der Meer J; Staugaard-Kloosterziel W
Acta Endocrinol (Copenh); 1971 May; 67(1):197-202. PubMed ID: 4324880
[No Abstract] [Full Text] [Related]
32. Aliskiren: an oral renin inhibitor for the treatment of hypertension.
Lam S; Choy M
Cardiol Rev; 2007; 15(6):316-23. PubMed ID: 18090068
[TBL] [Abstract][Full Text] [Related]
33. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
McMurray JJ; Pitt B; Latini R; Maggioni AP; Solomon SD; Keefe DL; Ford J; Verma A; Lewsey J;
Circ Heart Fail; 2008 May; 1(1):17-24. PubMed ID: 19808266
[TBL] [Abstract][Full Text] [Related]
34. Effect of ACE inhibitors and beta-blockers on homocysteine levels in essential hypertension.
Poduri A; Kaur J; Thakur JS; Kumari S; Jain S; Khullar M
J Hum Hypertens; 2008 Apr; 22(4):289-94. PubMed ID: 18200034
[TBL] [Abstract][Full Text] [Related]
35. Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
Gaddam KK; Oparil S
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):484-90. PubMed ID: 18695389
[TBL] [Abstract][Full Text] [Related]
36. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
Hollenberg NK
Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
[TBL] [Abstract][Full Text] [Related]
37. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
38. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism.
Weigel R; Hohenstein A; Schlickum L; Weiss C; Schilling L
Neurosurgery; 2007 Oct; 61(4):788-92; discussion 792-3. PubMed ID: 17986940
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
